NATURAL PRODUCTS FOR ANTI-ATHEROSCLEROTIC THERAPY

被引：0
|
作者：
Kirichenko, T. [1 ]
Orekhova, V. [1 ]
Myasoedova, V. [1 ]
Melnichenko, A. [1 ]
Sobenin, I. [1 ]
Orekhov, A. [1 ]
机构：
[1] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow, Russia
来源：
ATHEROSCLEROSIS | 2019年 / 287卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
10.1016/j.atherosclerosis.2019.06.455
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS19-0307
引用
收藏
页码：E152 / E152
页数：1
相关论文
共 50 条
  • [31] EFFECT OF PHARMACOLOGIC ANTI-ATHEROSCLEROTIC THERAPY ON CAROTID INTRAPLAQUE NEOVASCULARIZATION: A SYSTEMATIC REVIEW
    Cui, Edward
    Kersche, Georgia
    Grubic, Nicholas
    Hetu, Marie-France
    Pang, Stephen
    Johri, Amer
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1460 - 1460
  • [32] Unique vascular protective properties of natural products: supplements or future main-line drugs with significant anti-atherosclerotic potential?
    Slevin, Mark
    Ahmed, Nessar
    Wang, Qiuyu
    McDowell, Garry
    Badimon, Lina
    [J]. VASCULAR CELL, 2012, 4
  • [33] Novel Anti-inflammatory Interleukin-35 as an Emerging Target for Anti-atherosclerotic Therapy
    Bobryshev, Yuri V.
    Sobenin, Igor A.
    Orekhov, Alexander N.
    Chistiakov, Dimitry A.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (09) : 1147 - 1151
  • [34] Animal models to evaluate anti-atherosclerotic drugs
    Priyadharsini, Raman P.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 (04) : 329 - 340
  • [35] Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril
    Fonseca, FAH
    Ihara, SSM
    Izar, MCO
    Silva, EP
    Kasinski, N
    Lopes, IEL
    Pinto, LESA
    Paiva, TB
    Tufik, S
    de Paola, AAV
    Carvalho, ACC
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (10) : 779 - 785
  • [36] Anti-atherosclerotic effects of the hexapeptide angiotensin IV
    Vinh, Antony
    Widdop, Robert
    Gaspari, Tracey
    [J]. FASEB JOURNAL, 2008, 22
  • [37] Laboratory surrogates for anti-atherosclerotic drug development
    Stein, E
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (4A): : 21A - 26A
  • [38] Natural bioactive ingredients as plausible anti-atherosclerotic agent: evidence and hope from calycosin
    Berezin, Alexander E.
    [J]. ACTA CARDIOLOGICA, 2024, 79 (05) : 627 - 628
  • [39] Experimental study of the anti-atherosclerotic effect of demethylzeylasteral
    Huang, Ying
    Wang, Shaofeng
    Zhang, Chunya
    Xu, Zhiqing
    Shen, Jinghua
    Du, Xiaogang
    Zhang, Huanhua
    Zhang, Kangjian
    Zhang, Daifu
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (06) : 2787 - 2792
  • [40] ANTI-ATHEROSCLEROTIC EFFECTS OF SQUALENE SYNTHASE INHIBITORS
    Tavridou, A.
    Manolopoulos, V.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
12345